Why do heroin users refuse to participate in a heroin-assisted treatment trial?

被引:0
|
作者
Demaret, Isabelle [2 ]
Litran, Geraldine [2 ]
Magoga, Cecile [2 ]
Deblire, Clemence [2 ]
Dupont, Anicee [2 ]
De Roubaix, Jerome [1 ,2 ]
Lemaitre, Andre [1 ]
Ansseau, Marc [2 ]
机构
[1] Univ Liege, Inst Human & Social Sci Criminol, B-4000 Liege, Belgium
[2] Univ Liege, Dept Psychiat, B-4000 Liege, Belgium
关键词
Heroin; treatment; motivation; addiction; METHADONE; ADDICTS; NAOMI;
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Heroin-assisted treatment (HAT) can improve the condition of heroin addicts who are resistant to other treatments. However, in a new HAT trial in Belgium, fewer subjects than expected were included. Aim: Our research team explored the reasons given by heroin users in explaining why they did not want to participate. Methods: In 2011, during the trial recruitment, we interviewed heroin users (n=52) who never took the opportunity to meet the research team during the recruitment process preceding the trial. Results: Of those 52 heroin users, 25 were afraid of the limited length of the HAT and 11 feared becoming more dependent as a result of HAT. Conclusion: A trial that was planned to last for a limited length of time may have demotivated heroin users who could otherwise have benefited from this new programme.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 50 条
  • [1] Efficacy of Heroin-Assisted Treatment in Belgium: A Randomised Controlled Trial
    Demaret, Isabelle
    Quertemont, Etienne
    Litran, Geraldine
    Magoga, Cecile
    Deblire, Clemence
    Dubois, Nathalie
    De Roubaix, Jerome
    Charlier, Corinne
    Lemaitre, Andre
    Ansseau, Marc
    EUROPEAN ADDICTION RESEARCH, 2015, 21 (04) : 179 - 187
  • [2] Heroin-assisted treatment for opioid dependence - Randomised controlled trial
    Haasen, Christian
    Verthein, Uwe
    Degkwitz, Peter
    Berger, Juergen
    Krausz, Michael
    Naber, Dieter
    BRITISH JOURNAL OF PSYCHIATRY, 2007, 191 : 55 - 62
  • [3] Heroin-assisted treatment: no difference in treatment retention
    Al-Adwani, A.
    Nahata, R.
    BRITISH JOURNAL OF PSYCHIATRY, 2007, 191 : 458 - 458
  • [4] Craving and illicit heroin use among patients in heroin-assisted treatment
    Blanken, Peter
    Hendriks, Vincent M.
    Koeter, Maarten W. J.
    van Ree, Jan M.
    van den Brink, Wim
    DRUG AND ALCOHOL DEPENDENCE, 2012, 120 (1-3) : 74 - 80
  • [5] Screening for illicit heroin use in patients in a heroin-assisted treatment program
    Rook, Elisabeth J.
    Huitema, Alwin D. R.
    van den Brink, Wim
    Hillebrand, Michel J. X.
    van Ree, Jan M.
    Beijnen, Jos H.
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2006, 30 (06) : 390 - 394
  • [6] Staff concerns in heroin-assisted treatment centres
    Demaret, I.
    Lemaitre, A.
    Ansseau, M.
    JOURNAL OF PSYCHIATRIC AND MENTAL HEALTH NURSING, 2012, 19 (06) : 563 - 567
  • [7] Exploring why patients in heroin-assisted treatment are getting incarcerated—a qualitative study
    Maximilian Meyer
    Bernd Rist
    Johannes Strasser
    Undine E. Lang
    Marc Vogel
    Kenneth M. Dürsteler
    Marc Walter
    BMC Psychiatry, 22
  • [8] Deuterodiacetylmorphine as a marker for use of illicit heroin by addicts in a heroin-assisted treatment program
    Klous, MG
    Rook, EJ
    Hillebrand, MJX
    van den Brink, W
    van Ree, JM
    Beijnen, JH
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2005, 29 (06) : 564 - 569
  • [9] The Andalusian trial on heroin-assisted treatment: A 2 year follow-up
    Oviedo-Joekes, Eugenia
    March, Joan C.
    Romero, Manuel
    Perea-Milla, Emilio
    DRUG AND ALCOHOL REVIEW, 2010, 29 (01) : 75 - 80
  • [10] Patients' satisfaction with heroin-assisted treatment: a qualitative study
    Ellefsen, Rune
    Wusthoff, Linda Elise Couessurel
    Arnevik, Espen Ajo
    HARM REDUCTION JOURNAL, 2023, 20 (01)